IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS
批准号:
10272032
负责人:
David Sacks
金额:
$72.65万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AffectAnimal ModelAnti-Inflammatory AgentsAntibiotic ProphylaxisAntibioticsAttenuatedBacterial InfectionsBacterial TranslocationBiteBloodBlood VesselsBody Weight decreasedC57BL/6 MouseCCL24 geneCellsChronicClinical ResearchCutaneousCutaneous LeishmaniasisCytokine GeneDepositionDermalDermisDiseaseDisease ProgressionDoseEmbryoEnvironmentEquus caballusFamilyFlow CytometryGene Expression ProfileGoalsHamstersHematologyHepatosplenomegalyHeterogeneityHomeostasisHourHumanImmunologicsIndiaIndividualInfectionInfiltrationInflammatoryInterleukin-10Interleukin-13Interleukin-4IntestinesIronLeadLeishmaniaLeishmania donovaniLeishmania majorLeishmaniasisLesionLiverMalacoplakiaMediatingMediator of activation proteinModelingMolecularMusNeedlesOutcomeParasitesPathologyPatientsPhagocytesPlayPopulationPreventive vaccineProliferatingPropertyReceptor Protein-Tyrosine KinasesResistanceRoleSand FliesSiteSkinSmall inducible cytokine A24TissuesVaccinesVariantVisceral Leishmaniasiscell typecytokinedesigndrinking waterdysbiosiseosinophilexperimental studygut-liver axishealinghelminth infectionhost microbiotahuman modelimmunoreactionimmunoregulationintraperitonealintravital microscopymacrophagemicrobiotamouse modelneutrophilparasitismpathobiontpathogenprogramsprotective effectresponseskin disordertherapeutic vaccinetherapy developmenttransmission processtreatment responsevaccine development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Tissue-resident macrophages (TRMs) maintain tissue homeostasis, but they can also provide a replicative niche for intracellular pathogens such as Leishmania. We have identified a population of M2-like dermal macrophages that are present under steady state conditions and that are preferentially infected by a strain of Leishmania major isolated from a patient with chronic cutaneous lesions to promote non- healing cutaneous disease in conventionally resistant C57Bl/6 mice. The dermal macrophages are not replaced by blood precursors during infection, but are embryonic derived and locally maintained by IL-4 and IL-10 and retain M2 functionality despite the high levels of IFNg produced in the site. How dermal TRMs proliferate and maintain their M2 properties even in the strong TH1 environment of the L. major infected dermis is not clear. We show that in infected mice lacking IL-4/IL-13 from eosinophils, dermal TRMs shifted to a pro-inflammatory state, their numbers declined, and disease was attenuated. Intravital microscopy revealed a rapid infiltration of eosinophils followed by their tight interaction with dermal TRMs. IL-4-stimulated dermal TRMs, in concert with IL-10, produced a large amount of CCL24 (Eotaxin-2) which functioned to amplify eosinophil influx and their interaction with dermal TRMs. An intraperitoneal helminth infection model also demonstrated a requirement for eosinophil-derived IL-4 to maintain tissue macrophages through a CCL24-mediated amplification loop. CCL24 secretion was confined to resident macrophages in other tissues, implicating eosinophil-TRM cooperative interactions in diverse inflammatory settings.
There is substantial experimental evidence to indicate that Leishmania infections that are transmitted naturally by the bites of infected sand flies differ in fundamental ways from the inflammatory and immune reactions initiated by needle inocula. We have used flow cytometry and intravital microscopy (IVM) to reveal the heterogeneity of sand fly transmission sites with respect to the subsets of phagocytes in the skin that harbor L. major within the first hours and days after infection. By flow cytometry analysis, dermis resident macrophages (TRMs) were on average the predominant infected cell type at 1 hr and 24 hr. By confocal intravital microscopy, the co-localization of L. major and neutrophils varied depending on the proximity of deposited parasites to the site of vascular damage, defined by the highly localized swarming of neutrophils. Some of the dermal TRMs could be visualized acquiring their infections via transfer from or efferocytosis of parasitized neutrophils, providing direct evidence for the Trojan Horse model. The role of neutrophil engulfment by dermal TRMs and the involvement of the Tyro3/Axl/Mertk family of receptor tyrosine kinases in these interactions and in sustaining the anti-inflammatory program of dermal TRMs was supported by the effects observed in neutrophil depleted and in Axl-/-Mertk-/- mice. The Axl-/-Mertk-/- mice also displayed reduced parasite burdens but more severe pathology following L. major infection transmitted by sand fly bite. The heterogeneity of sand fly transmission sites with respect to the dose of parasites and the early cellular interactions that we describe likely contribute to the wide range of infection outcomes that are associated with natural transmission of L. major observed in mouse models and humans.
Leishmania donovani causes visceral leishmaniasis (VL), which is typically fatal without treatment. There is substantial variation between individuals in rates of disease progression and response to treatment. The reasons for heterogeneous disease presentation in humans and animal models are poorly understood. Host microbiota has become established as a factor in cutaneous forms of leishmaniasis but this has not been studied in VL. We induced intestinal dysbiosis in mice and hamsters by long-term treatment with broad-spectrum antibiotics in their drinking water. There were no significant differences in disease presentation in dysbiotic mice. In contrast, dysbiotic hamsters infected with L. donovani had delayed onset and progression of weight loss. Antibiotic-treated hamsters also had significantly less severe hepatosplenomegaly, which was accompanied by a distinct cytokine gene expression profile. The protective effect was not explained by differences in parasite loads or hematological profiles. We further found evidence that the gut-liver axis is a key aspect of fatal VL progression in hamsters, including intestinal parasitism, bacterial translocation to the liver, malakoplakia and iron sequestration, none of which occurred in non-progressing murine VL. Diverse bacterial genera were cultured from VL affected livers, of which Rodentibacter was specifically absent from ABX-treated hamsters, indicating this pathobiont may play a role in promoting disease progression. The results provide experimental support for antibiotic prophylaxis against secondary bacterial infections as an adjunct therapy in human VL patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ANALYSIS OF T CELL RESPONSES IN HUMAN LEISHMANIASIS
-
批准号:6431576
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:David Sacks
-
依托单位:
Developmental Biology Of Leishmania Promastigotes
-
批准号:6668897
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:David Sacks
-
依托单位:
IQGAP1 in tumorigenesis
-
批准号:8565384
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:David Sacks
-
依托单位:
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS
-
批准号:8745304
-
项目类别:
-
资助金额:$72.5万
-
财政年份:--
-
负责人:David Sacks
-
依托单位:
Vector Biological Studies in Leishmaniasis
-
批准号:8946248
-
项目类别:
-
资助金额:$46.77万
-
财政年份:--
-
负责人:David Sacks
-
依托单位:
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS
-
批准号:9563834
-
项目类别:
-
资助金额:$52.93万
-
财政年份:--
-
负责人:David Sacks
-
依托单位:
Vector Biological Studies in Leishmaniasis
-
批准号:10014015
-
项目类别:
-
资助金额:$91.18万
-
财政年份:--
-
负责人:David Sacks
-
依托单位:
IQGAP1 in tumorigenesis
-
批准号:8952889
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:David Sacks
-
依托单位:
Vector Biological Studies in Leishmaniasis
-
批准号:10692011
-
项目类别:
-
资助金额:$77.51万
-
财政年份:--
-
负责人:David Sacks
-
依托单位:
Analysis Of T Cell Responses In Leishmaniasis
-
批准号:6808222
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:David Sacks
-
依托单位:
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS
-
批准号:7732462
-
项目类别:
-
资助金额:$65.59万
-
财政年份:--
-
负责人:David Sacks
-
依托单位:
Vector Biological Studies in Leishmaniasis
-
批准号:8156818
-
项目类别:
-
资助金额:$72.29万
-
财政年份:--
-
负责人:David Sacks
-
依托单位:
Analysis Of T Cell Responses In Leishmaniasis
-
批准号:6669482
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:David Sacks
-
依托单位:
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS
-
批准号:7592158
-
项目类别:
-
资助金额:$85.08万
-
财政年份:--
-
负责人:David Sacks
-
依托单位:
Vector Biological Studies in Leishmaniasis
-
批准号:8336033
-
项目类别:
-
资助金额:$66.38万
-
财政年份:--
-
负责人:David Sacks
-
依托单位:
Vector Biological Studies in Leishmaniasis
-
批准号:8555740
-
项目类别:
-
资助金额:$54.6万
-
财政年份:--
-
负责人:David Sacks
-
依托单位:
Vector Biological Studies in Leishmaniasis
-
批准号:8745278
-
项目类别:
-
资助金额:$48.33万
-
财政年份:--
-
负责人:David Sacks
-
依托单位:
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS
-
批准号:10692024
-
项目类别:
-
资助金额:$77.51万
-
财政年份:--
-
负责人:David Sacks
-
依托单位:
IQGAP1 in tumorigenesis
-
批准号:10913210
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:David Sacks
-
依托单位:
Vector Biological Studies in Leishmaniasis
-
批准号:7299906
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:David Sacks
-
依托单位:
海外基金